Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hemorrhage
Description
Bleeding or escape of blood from a vessel. MeSH
Hierarchy View
Subtype Terms (21)
Blood Loss, Surgical
61 drugs (44 approved, 17 experimental)
Ecchymosis
8 drugs (5 approved, 3 experimental)
Epistaxis
19 drugs (16 approved, 3 experimental)
Gastrointestinal Hemorrhage
27 drugs (21 approved, 6 experimental)
Hematoma
18 drugs (12 approved, 6 experimental)
Hematuria
13 drugs (11 approved, 2 experimental)
Hemoptysis
7 drugs (6 approved, 1 experimental)
Hemothorax
1 approved drug
Intracranial Hemorrhages
41 drugs (35 approved, 6 experimental)
Oral Hemorrhage
4 approved drugs
Postoperative Hemorrhage
22 drugs (18 approved, 4 experimental)
Purpura
52 drugs (35 approved, 17 experimental)
Shock, Hemorrhagic
19 drugs (11 approved, 8 experimental)
Uterine Hemorrhage
16 approved drugs
Approved Indicated Drugs (16)
Phase 4 Indicated Drugs (61)
Phase 2 Indicated Drugs (23)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (19)
Organization Involved with Phase 4 Indications (274)
Adolphe Rothschild Ophtalmologic Foundation
Al- Elweyia Maternity Teaching Hospital
Amphia Hospital Breda, the Netherlands
Azienda Ospedaliera San Gerardo di Monza
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Burnasyan Federal Medical Biophysical Center
Cantonal Hospital of St. Gallen
Central California Faculty Medical Group
Centre Hospitalier de Montauban
Centre Hospitalier Universitaire de Nīmes
Centre of Postgraduate Medical Education
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Clinique Mutualiste Chirurgicale de la Loire
College of Medical Sciences Teaching hospital, Bharatpur, Nepal
College of Medical Sciences Teaching Hospital. Nepal
Eastern Virginia Medical School
Family Planning Association New South Wales
French Health Products Safety Agency
Fundacion Clinic per a la Recerca Biomédica
Glasgold Group Plastic Surgery
Grupo de Estudos Multicentricos em Onco-Hematologia
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangdong Second Provincial Traditional Chinese Medicine Hospital
Guangzhou Bioseal Biotechnology Co., Ltd.
Guangzhou Pharmaceucal Company Limited
Icahn School of Medicine at Mount Sinai
Instituto de Medicina Integral Professor Fernando Figueira
Instituto Nacional de Traumatologia e Ortopedia
Kanuni Sultan Suleyman Training and Research Hospital
Katholieke Universiteit Leuven
Kim's Eye Hospital, Seoul, South Korea
Laboratoire français de Fractionnement et de Biotechnologies
Maria Sklodowska Curie Children's Hospital
Maternidade Escola Assis Chateaubriand
Mayfield Clinic & Spine Institute
Medical University of Bialystok
Medical University of South Carolina
Moorgreen Hospital, Southampton
National Autonomous University of Mexico
National Cheng Kung University
National Institutes of Health (NIH)
National University of Singapore
Norwegian University of Science and Technology
Oregon Health and Science University
Ospedale Maggiore San Giovanni Bosco
People's Liberation Army of China
Postgraduate Institute of Medical Education and Research
Rio de Janeiro State University
Society for Obstetric Anesthesia and Perinatology
St. Antonius Hospital, Nieuwegein
Sydney Centre for Reproductive Health Research
Taichung Veterans General Hospital
Taipei Veteran General hospital
The First People's Hospital of Jingzhou
The Physicians' Services Incorporated Foundation
The Sixth People Hospital of Shenyang
The University of Texas, Dallas
Tianjin Second People's Hospital
Universidad Autonoma de Barcelona
Universidad Autonoma de Nuevo Leon
University Hospital Hradec Kralove
University of British Columbia
University of California, Davis
University of California, Los Angeles
University of California, San Francisco
University of Nice Sophia Antipolis
University of Roma La Sapienza
University of Texas at Houston
University of Texas, San Antonio
Vita-Salute University of Milano. Italy
Washington University in St. Louis
Organization Involved with Phase 3 Indications (222)
Aase and Ejnar Danielsens Foundation
Alabama Liver & Digestive Specialists Research Center
Assistance Publique - Hôpitaux de Paris
Australian and New Zealand Intensive Care Society Clinical Trials Group
Azienda U.S.L. 1 di Massa e Carrara
Basildon and Thurrock University Hospitals NHS Foundation Trust
Blood Bank of the Danish capital region
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR)
Casa Sollievo della Sofferenza IRCCS
Casa Sollievo della Sofferenza, San Giovanni Rotondo
Case Western Reserve University
Central Hospital, Dijon, France
Centro Cochrane Iberoamericano. IIB Sant Pau
Charlotte Eye Ear Nose and Throat Assciates, PA
Coombe Women and Infants University Hospital
Danish Council for Independent Research
Defence Research and Development Canada
Direction Centrale du Service de Santé des Armées
East Kent Hospitals University NHS Foundation Trust
Ecoles militaires de santé de Lyon-Bron
Federal University of Rio de Janeiro
General Committee of Teaching Hospitals and Institutes, Egypt
Gloucestershire Hospitals NHS Foundation Trust
Gottfried Wilhelm Leibniz Universität Hannover
Hamilton Health Sciences Corporation
Health Insurance Organization, Egypt
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Institut National de la Santé Et de la Recherche Médicale, France
Jaeb Center for Health Research
Japan Cardiovascular Research Foundation
Jawaharlal Nehru Medical College
Kermanshah University of Medical Sciences
KK Women's and Children's Hospital
Livzon Pharmaceutical Group Inc.
Maccabi Healthcare Services, Israel
Mbarara University of Science and Technology
Mid Yorkshire Hospitals NHS Trust
National Cerebral and Cardiovascular Center
National Health and Medical Research Council, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Health Research, United Kingdom
National Institute of Child Health and Human Development (NICHD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Maternity Hospital, Ireland
National University of Ireland
Netherlands Organisation for Scientific Research
Northumbria Healthcare NHS Foundation Trust
Omrix Biopharmaceuticals, Inc.
Pediatric Emergency Care Applied Research Network
Royal College of Surgeons, Ireland
Salford Royal Foundation NHS Trust
Shaanxi Provincial People's Hospital
Swiss National Science Foundation
Taunton and Somerset NHS Foundation Trust
Technical University of Munich
The First People's Hospital of Changzhou
The New England Baptist Hospital
Universidad Autónoma de Aguascalientes
Organization Involved with Phase 2 Indications (97)
Alberta Heritage Foundation for Medical Research
Alex Ekwueme Federal University Teaching Hospital
Beijing Fangshan District Liangxiang Hospital
Centre Chirurgical Marie Lannelongue
Federal University of Rio Grande do Sul
Heart and Stroke Foundation of Canada
Hoosier Cancer Research Network
Huazhong University of Science and Technology
Instituto Chileno de Medicina Reproductiva
International Neuroscience Institute Hanover
JP Moulton Charitable Foundation
Laboratorio Elea S.A.C.I.F. y A.
National Cancer Institute (NCI)
National Neuroscience Institute
Qazvin University Of Medical Sciences
State University of New York, Buffalo
Sunnybrook Health Sciences Centre
The Florey Institute of Neuroscience and Mental Health
Universidad Autonoma de San Luis Potosi
University of North Carolina at Chapel Hill
University of Southern California
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 1 Indications (32)
Organization Involved with Other Experimental Indications (114)
American College of Obstetricians and Gynecologists
American Society for Gastrointestinal Endoscopy
Anhui College of Traditional Chinese Medicine
Bill and Melinda Gates Foundation
Canadian Anesthesiologists' Society
D'Annunzio University of Chieti–Pescara
Dongguan Maternity & Child Health Hospital
Dr. D. Y. Patil Dental College & Hospital
Dr. Sami Ulus Children's Hospital
European Cardiovascular Research Center
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Grupo Mexicano para el Estudio de la Medicina Intensiva
Harborview Injury Prevention and Research Center
Health Bureau Tibet Autonomous Region
Hospital Gineco Obstetrico Isidro Ayora
Ilam University of Medical Sciences
Institute of Liver and Biliary Sciences, India
Jiangmen Maternity & Child Health Care Hospital
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Kurdistan Board for Medical Speciality
Mbale Regional Referral Hospital
Medical Centre of Postgraduate Education, Poland
MOH Etlik Zubeyde Hanim Women's Health Training and Research Hospital
Nanhai Maternity & Child Healthcare Hospital
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of General Medical Sciences (NIGMS)
National University of Malaysia
New York City Health and Hospitals Corporation
Odontologisk Forskning i Region Skåne (OFRS)
Second People's Hospital of Lanzhou
Secretariat of His Highness the Aga Khan, Aiglemont
Silesian University of Medicine
Sisters of Mercy University Hospital
State University of New York, Brooklyn
The Second Clinical Medical College of Jinan University
United States Agency for International Development
University of Illinois at Chicago
University of Picardie Jules Verne
University of Southern Denmark
University of Tennessee, Chattanooga
University of the Witwatersrand
University of Western Australia
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
